Skip to content
Business
Prognosis

WHO Panel Advises Against Generic Antidepressant to Treat Covid

A healthcare worker conducts a Covid-19 rapid test at a drive through testing site in Cruz Bay, Saint John, U.S. Virgin Islands.

A healthcare worker conducts a Covid-19 rapid test at a drive through testing site in Cruz Bay, Saint John, U.S. Virgin Islands.

Photographer: Gabby Jones/Bloomberg

A generic antidepressant and a gout medicine that garnered some popularity as Covid-19 treatments shouldn’t be used for mild infection because there’s no evidence they help, according to a panel of experts advising the World Health Organization.

The drugs, fluvoxamine and colchicine, could potentially cause harm, the group of experts said in the BMJ medical journal Thursday. The panel didn’t give advice for severe illness, saying there was a lack of data.